Pet Blood Pressure Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Dogs, Cats, Other Pets), By Product (Devices, Consumables), By Technology (Aneroid, Automatic), By End User (Veterinary Hospitals, Veterinary Clinics, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 140.11 Million
CAGR (2026-2031)	7.77%
Fastest Growing Segment	Veterinary Hospitals
Largest Market	North America
Market Size (2031)	USD 219.51 Million

Market Overview

The Global Pet Blood Pressure Monitoring Devices Market will grow from USD 140.11 Million in 2025 to USD 219.51 Million by 2031 at a 7.77% CAGR. Pet blood pressure monitoring devices are veterinary medical instruments designed to measure arterial pressure in companion animals, utilizing either non-invasive oscillometric and Doppler techniques or invasive catheter-based methods to detect hypertension and hypotension. The expansion of this market is primarily supported by the increasing prevalence of age-related conditions such as chronic kidney disease and the growing trend of pet humanization which drives demand for preventive diagnostics. According to the American Veterinary Medical Association, in 2024, the United States dog population reached 89.7 million while the cat population rose to 73.8 million, significantly expanding the potential patient base for these diagnostic tools.

Despite these strong growth drivers, the market faces a significant obstacle regarding the accuracy of measurements in clinical settings due to animal behavior. High anxiety levels in patients often lead to the white-coat effect or movement artifacts which can distort readings and complicate the diagnosis of genuine pathological hypertension. This technical difficulty necessitates repeated confirmations and extensive staff training which may deter smaller veterinary practices from investing in or routinely utilizing these monitors.

Key Market Drivers

The surge in veterinary healthcare expenditure acts as a critical engine for the market by altering the accessibility of diagnostic tools. As owners prioritize wellness, there is a willingness to invest in monitoring for chronic conditions which allows practices to integrate superior quality blood pressure protocols. This financial commitment is quantified by recent data as according to Synchrony, June 2025, in the 'Pet Lifetime of Care Study', the lifetime cost of care for a dog has risen to between $22,125 and $60,602. This substantial capital dedication directly supports the procurement of specialized monitoring devices. Reinforcing this market expansion, according to IDEXX Laboratories, in 2025, the company reported 7% organic growth in Companion Animal Group Diagnostics recurring revenue for the previous year, highlighting the global demand for clinical testing.

Simultaneously, the growing adoption of pet insurance is dismantling financial barriers associated with sustained disease management. Hypertension requires regular screening which creates a recurring cost that uninsured clients often decline. Insurance coverage ensures veterinarians can adhere to best practice monitoring without owner resistance based on price. This trend is evident as according to the North American Pet Health Insurance Association, April 2025, in the 'State of the Industry Report', total premium volume in the U.S. reached $4.7 billion at the end of 2024. As coverage expands to include geriatric care, the utilization of blood pressure devices is becoming a standard and reimbursed component of veterinary protocols.

Download Free Sample Report

Key Market Challenges

The primary impediment hampering the growth of the Global Pet Blood Pressure Monitoring Devices Market is the unreliability of clinical measurements caused by animal behavior. Companion animals frequently experience high anxiety in veterinary settings, resulting in the "white-coat effect" or movement artifacts that produce inaccurate blood pressure readings. This technical volatility forces veterinary professionals to perform repeated confirmations to distinguish between stress-induced spikes and genuine pathological hypertension, a process that significantly impedes clinical workflow and consumes valuable appointment time.

Consequently, this diagnostic uncertainty reduces the return on investment for smaller practices that cannot afford the operational delays associated with difficult patient handling or extensive staff training. According to the American Veterinary Medical Association, in 2024, patient visits across veterinary practices declined by 2.3% compared to the previous year, creating an economic environment where operational efficiency is paramount. In this context, the time-intensive nature of obtaining accurate blood pressure data acts as a deterrent to widespread adoption, as clinics prioritize diagnostic tools that offer immediate, reliable results without disrupting strict appointment schedules.

Key Market Trends

The market is prioritizing the advancement of species-specific diagnostic algorithms to mitigate inaccuracies caused by animal anxiety. Manufacturers are increasingly leveraging large-scale datasets to refine oscillometric software, allowing devices to distinguish between genuine hypertension and stress-induced artifacts like the "white-coat effect" with greater precision. This technological maturation is driven by substantial clinical research validating these algorithms against invasive standards to ensure reliability. Specifically, according to Mars Veterinary Health, April 2025, in the 'Science Impact Report', the organization authored over 450 peer-reviewed publications and facilitated clinical trials across more than 140 locations, highlighting the industry-wide commitment to generating the rigorous data necessary to optimize these diagnostic tools for diverse veterinary patients.

Concurrently, the incorporation of blood pressure data into veterinary telemedicine platforms is transforming chronic disease management workflows. This integration enables veterinarians to monitor hypertensive patients in their home environments, thereby obtaining representative "resting" blood pressure values that are free from clinical stressors. The viability of this remote care model is heavily supported by the expanding population of insured pets, whose policies increasingly cover tele-triage and digital health services. This trend is substantiated as according to the North American Pet Health Insurance Association, April 2025, in the 'State of the Industry Report', the total number of insured pets in North America reached 7.03 million at the end of 2024, confirming a robust user base for connected monitoring adoption.

Segmental Insights

The Veterinary Hospitals segment is experiencing rapid growth in the Global Pet Blood Pressure Monitoring Devices Market due to the increasing volume of complex surgical procedures and emergency cases that demand precise vital sign tracking. These facilities are the primary providers of critical care for conditions such as systemic hypertension and renal disease, necessitating advanced diagnostic capabilities. Furthermore, the American Animal Hospital Association (AAHA) recommends continuous blood pressure evaluation during general anesthesia, compelling hospitals to integrate reliable monitoring systems to ensure patient safety. This adherence to elevated standards of care significantly drives the adoption of monitoring devices within this sector.

Regional Insights

North America commands the leading position in the Global Pet Blood Pressure Monitoring Devices Market, driven by a robust veterinary healthcare infrastructure and high disposable income dedicated to companion animal wellness. This dominance is significantly influenced by the strong emphasis on preventive care and the early detection of conditions such as hypertension and renal disease. Furthermore, the American Animal Hospital Association (AAHA) plays a pivotal role by establishing clinical guidelines that recommend routine blood pressure screening, thereby accelerating device adoption among veterinary professionals. The presence of major device manufacturers within the region further ensures high product accessibility and market penetration.

Recent Developments

• In September 2024, Mindray Animal Medical globally debuted its "Orange Label" series of veterinary medical equipment, which includes the Vetal 3 veterinary monitor. This new series was developed to address the dynamic needs of modern animal hospitals, featuring intuitive smart tools and a distinct, user-friendly interface designed for ease of adoption. The monitors in this series are equipped with optimized algorithms for non-invasive blood pressure and other vital parameters, ensuring stable and precise measurements for daily practice. The launch represents a significant expansion of the company's portfolio, aiming to provide comprehensive, accessible, and high-quality monitoring solutions for veterinarians worldwide.
• In May 2024, Bionet America, Inc. unveiled the Brio XVet series, a new line of veterinary multiparameter monitors intended to improve clinical workflow and patient safety. The series includes three models with varying touchscreen sizes, all equipped with essential monitoring capabilities such as non-invasive blood pressure, ECG, and SpO2. These monitors are integrated with proprietary software that automatically captures vital signs during procedures, allowing staff to focus more on patient care. The launch emphasizes the company's commitment to providing precise and efficient monitoring solutions for veterinary surgeries and routine check-ups.
• In February 2024, Midmark Corporation announced the launch of its new multiparameter monitors, which are designed to enhance anesthesia monitoring for veterinary professionals. These devices incorporate Cardell blood pressure technology, which utilizes veterinary-specific algorithms validated for accuracy in anesthetized cats and dogs. The monitors feature a pre-procedure checklist and best-practice guides to improve safety and efficiency during surgeries. Available in different screen sizes, the monitors allow for customizable user displays and help veterinary teams make informed decisions by matching abnormal waveforms to common anesthetic occurrences, thereby supporting better patient outcomes.
• In January 2024, SunTech Medical introduced the Vet40, a comprehensive surgical vital signs monitor designed specifically for companion animals and equines. This new device expands upon the company's established veterinary blood pressure product line by integrating their proprietary animal-specific blood pressure algorithm with other essential vital sign measurements. The monitor features a user-friendly touchscreen interface and is capable of measuring non-invasive blood pressure, temperature, pulse oximetry, and electrocardiogram data. It was engineered to operate quietly to reduce stress in nervous animals and includes customizable alarms, making it a versatile solution suitable for both exam rooms and surgical environments.

Key Market Players

• SunTech Medical Inc.
• CONTEC MEDICAL SYSTEMS CO.,LTD
• TOOTOO MEDITECH, CO., LTD
• New Gen Medical Systems
• Ramsay Health Care Limited
• Panlab, S.L.U
• KeeboMed Inc.
• AD Instruments NZ Limited.
• Shenzhen Mindray Animal Medical Technology Co., LTD.
• Midmark Corporation

By Animal Type	By Product	By Technology	By End User	By Region
Dogs Cats Other Pets	Devices Consumables	Aneroid Automatic	Veterinary Hospitals Veterinary Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Pet Blood Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Pet Blood Pressure Monitoring Devices Market, By Animal Type:

• Dogs
• Cats
• Other Pets

• Pet Blood Pressure Monitoring Devices Market, By Product:

• Devices
• Consumables

• Pet Blood Pressure Monitoring Devices Market, By Technology:

• Aneroid
• Automatic

• Pet Blood Pressure Monitoring Devices Market, By End User:

• Veterinary Hospitals
• Veterinary Clinics
• Others

• Pet Blood Pressure Monitoring Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE